Anaesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Physical status: ASA I and II. Age: between 21 and 60 years old.
Exclusion criteria
Exclusion criteria: Refusal of informed consent for regional anaesthesia. Known Allergy to one of the study drugs. History or evidence of coagulopathy, use of anti-coagulant, anti-platelet therapy, or infection at the injection site. Patients with a history of drug abuse. Patients with a history of upper limb neuronal injury at the same limb of the block. Patients with history of respiratory distress for fear of diaphragmatic paralysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the time interval after which there will be a requirement of the first supplemental dose of rescue analgesia (Pethidine 50mg IM) with NRS =4. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome is the total dose of pethidine that will be received as rescue analgesia in 1st 24 hours postoperatively, hemodynamics and complications such as nausea, vomiting, and respiratory distress due to diaphragmatic paralysis assessed by chest ultrasound or pneumothorax assessed clinically and by A-P chest X-ray. | — |
Countries
Egypt
Contacts
Consultant